CTOs on the Move

Mpathy Medical

www.mpathymedical.com

 
Mpathy Medical is a Raynham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Huntsville Hospital

Huntsville Hospital is an 881-bed hospital that was established in Huntsville, Alabama in 1895. A community-based, not-for-profit institution, Huntsville Hospital is the second largest hospital in Alabama and the sixth largest publicly owned hospital system in the nation. Huntsville Hospital employs nearly 7,000 employees and has a Medical Staff with more than 750 physicians. Huntsville Hospital serves as the major referral hospital and trauma center for patients throughout the Tennessee Valley and is a teaching facility for UAB`s Family Practice and Internal Medicine Residency Programs.

Health Care Financing Administration

Health Care Financing Administration is a Gwynn Oak, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jupiter Medical Center

Jupiter Medical Center, your not for profit community hospital. As the area`s #1 Preferred Hospital, Jupiter Medical Center delivers compassionate care, at the forefront of clinical innovation. World-class care is close at hand with our team of leading healthcare professionals, our specialized centers and the latest technologies for diagnosis and treatment.

Liberty Healthcare Management

Liberty Healthcare Management is a Ramsey, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scynexis

SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.